We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A
BIO

203 hedge funds and large institutions have $2.05B invested in Bio-Rad Laboratories Class A in 2013 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 81 increasing their positions, 62 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

336% more call options, than puts

Call options by funds: $1.54M | Put options by funds: $353K

35% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 20

31% more repeat investments, than reductions

Existing positions increased: 81 | Existing positions reduced: 62

3% more funds holding

Funds holding: 198 → 203 (+5)

4% more capital invested

Capital invested by funds: $1.97B → $2.05B (+$77.9M)

0.36% less ownership

Funds ownership: 75.05% → 74.69% (-0.36%)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
203
Holders Change
+5
Holders Change %
+2.53%
% of All Funds
6.58%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.1%
New
27
Increased
81
Reduced
62
Closed
20
Calls
$1.54M
Puts
$353K
Net Calls
+$1.19M
Net Calls Change
+$222K

Top Buyers

Rank Fund Capital Flow
1
American Century Companies
American Century Companies
Missouri
+$29.6M
2
FWIA
Fort Washington Investment Advisors
Ohio
+$23.5M
3
LCS
Levin Capital Strategies
New York
+$15M
4
AI
Ariel Investments
Illinois
+$9.93M
5
Wells Fargo
Wells Fargo
California
+$9.55M

Top Sellers

Rank Fund Capital Flow
1
BBHC
Brown Brothers Harriman & Co
New York
-$72.6M
2
TCM
TimesSquare Capital Management
New York
-$26.2M
3
RA
Royce & Associates
New York
-$12.5M
4
BIT
BlackRock Institutional Trust
California
-$11.4M
5
CA
Commerzbank Aktiengesellschaft
Germany
-$11.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Norges Bank
26
Norges Bank
Norway
$18.2M +$5.98M +50,719 +49%
First Trust Advisors
27
First Trust Advisors
Illinois
$16.4M +$2.9M +24,623 +21%
Charles Schwab
28
Charles Schwab
California
$15.8M +$2.58M +21,846 +20%
PAMP
29
Polar Asset Management Partners
Ontario, Canada
$14.9M +$2.04M +17,298 +16%
Dimensional Fund Advisors
30
Dimensional Fund Advisors
Texas
$13.6M +$869K +7,370 +7%
VOYA Investment Management
31
VOYA Investment Management
Georgia
$11.5M +$413K +3,505 +4%
GI
32
GAMCO Investors
Connecticut
$11.4M – – –
Geode Capital Management
33
Geode Capital Management
Massachusetts
$10.3M +$473K +4,008 +5%
KCM
34
Kennedy Capital Management
Missouri
$10M -$743K -6,304 -7%
Jacobs Levy Equity Management
35
Jacobs Levy Equity Management
New Jersey
$10M -$423K -3,590 -4%
CRCP
36
Copper Rock Capital Partners
Massachusetts
$9.6M -$233K -1,974 -2%
TRSOTSOK
37
Teachers Retirement System of the State of Kentucky
Kentucky
$9.05M -$1.11M -9,400 -11%
VAM
38
Visium Asset Management
New York
$8.96M +$4.96M +42,066 +123%
Renaissance Technologies
39
Renaissance Technologies
New York
$8.43M -$3.72M -31,500 -31%
TCIM
40
TIAA CREF Investment Management
New York
$7.85M -$436K -3,694 -5%
D.E. Shaw & Co
41
D.E. Shaw & Co
New York
$7.62M +$4.14M +35,102 +118%
California Public Employees Retirement System
42
California Public Employees Retirement System
California
$7.6M +$245K +2,078 +3%
EAM
43
Eagle Asset Management
Florida
$7.46M +$377K +3,193 +5%
AAMU
44
Amundi Asset Management US
Massachusetts
$7.34M -$118K -1,000 -2%
Ameriprise
45
Ameriprise
Minnesota
$7.19M +$346K +2,936 +5%
Two Sigma Investments
46
Two Sigma Investments
New York
$7.01M -$1.57M -13,309 -18%
BIM
47
BlackRock Investment Management
Delaware
$6.91M +$522K +4,425 +8%
New York State Common Retirement Fund
48
New York State Common Retirement Fund
New York
$6.78M -$64.9K -550 -0.9%
GC
49
Guggenheim Capital
Illinois
$6.59M +$1.62M +13,734 +32%
Bank of America
50
Bank of America
North Carolina
$6.49M +$177K +1,503 +3%
1
2
3 4 5

BIO Hedge Fund Activity: Q3 2013 in Review

203 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q3 2013, worth a combined $2.05B — up 3.9% from $1.97B a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new BIO positions and 20 closed out — a net gain of 7 holders — while 81 added to existing stakes and 62 trimmed.

The largest buyer was American Century Companies, opening a new position worth an estimated $29.6M. The largest seller was Brown Brothers Harriman & Co, cutting an estimated $72.6M.

  • 203 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q3 2013, up from 198 in Q2 2013.
  • Funds reported $2.05B of Bio-Rad Laboratories Class A stock for Q3 2013, up 3.9% quarter-over-quarter.
  • 27 funds opened new Bio-Rad Laboratories Class A positions in Q3 2013 and 20 closed out, a net change of +7 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q3 2013 was American Century Companies, an estimated $29.6M added.
  • The largest Bio-Rad Laboratories Class A seller in Q3 2013 was Brown Brothers Harriman & Co, an estimated $72.6M sold.

Based on aggregated 13F filings for Q3 2013.